5134.KLSE Southern Acids (M) Bhd
- Market cap
- MYR 412M
- P/E
- 7.9x
- P/B
- 0.52x
- ROE
- 7.4%
- Dividend yield
- 1.66%
- Fundamental score
- 2.5/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 5134.KLSE undervalued?
Graham number5134.KLSE trades 57.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Southern Acids (M) Bhd fundamental analysis
12 of 22 checks passedROE 0/2
Low return on equity (7.4%), below 10%.
ROA 1/1
Return on assets (5.6%) is above the industry median (1.8%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (1.8%) is above the 5-year average (0.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (1.8%) is below the industry median (43.3%).
Revenue Growth 0/2
Revenue shrank 5.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 60.0x against interest expense, well covered.
PE vs Market 1/1
PE (7.9x) is below the market median (11.4x).
PE vs Industry 1/1
PE (7.9x) is below the industry median (9.5x).
PBV 0/1
Price to book (0.5x) is above the industry median (0.4x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 4.2, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 705.91, above 1.
Dividend Yield 0/2
Dividend yield (1.7%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 2/2
Dividends paid without a cut of more than 10% for 11 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 18.3%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Southern Acids (M) Bhd
Southern Acids (M) Berhad, an investment holding company, engages in the manufacture and trading of oleochemical products in Malaysia, Indonesia, rest of Asia, Europe, the United States, and internationally. It operates through four segments: Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The company offers fatty acids and glycerine for use in various applications, including personal care, cleaning agents, cosmetic, pharma…
Full company profileSouthern Acids (M) Bhd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Southern Acids (M) Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 740M | 763M | 599M | 660M | 741M | 1.18B | 1.10B | 908M | 1.09B | 919M | 943M |
| Gross Profit | 232M | 196M | 190M | 197M | 203M | 293M | 238M | 176M | 225M | 196M | 171M |
| Operating Income | 75.1M | 50.8M | 38.5M | 49.4M | 60.9M | 151M | 75.7M | 44.5M | 73.7M | 62.0M | 108M |
| EBITDA | - | 67.1M | 54.4M | 69.0M | 82.7M | 174M | 100M | 68.9M | 100M | 104M | 136M |
| Net Income | 48.7M | 32.6M | 21.5M | 32.0M | 37.4M | 94.4M | 33.3M | 13.6M | 36.7M | 37.4M | 58.1M |
| EPS | 0.36 | 0.24 | 0.16 | 0.23 | 0.27 | 0.69 | 0.24 | 0.10 | 0.27 | 0.27 | 0.42 |
| Balance Sheet | |||||||||||
| Total Assets | 705M | 717M | 732M | 727M | 811M | 968M | 973M | 1.02B | 1.01B | 1.03B | 1.04B |
| Total Liabilities | 136M | 131M | 130M | 133M | 173M | 241M | 218M | 239M | 228M | 139M | 151M |
| Shareholders' Equity | 569M | 586M | 601M | 594M | 638M | 727M | 755M | 780M | 780M | 782M | 786M |
| Cash & Short-term Investments | 164M | 174M | 200M | 209M | 242M | 322M | 386M | 397M | 385M | 439M | 453M |
| Total Debt | - | 123K | 212K | 8.66M | 6.62M | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 17.2M | 56.3M | 65.7M | 29.8M | 48.5M | 85.2M | 109M | 28.0M | 51.2M | 116M | 44.7M |
| Capital Expenditure | 21.4M | 34.5M | 39.0M | 15.8M | 23.0M | 20.4M | 25.8M | 33.9M | 38.6M | 35.1M | 10.0M |
| Free Cash Flow | - | 21.8M | 26.7M | 14.0M | 24.9M | 64.7M | 84.8M | -5.90M | 17.5M | 80.8M | 34.7M |
| Ratios | |||||||||||
| ROE | 8.6% | 5.6% | 3.6% | 5.4% | 5.9% | 13.0% | 4.4% | 1.7% | 4.7% | 4.8% | 7.4% |
| ROA | 6.9% | 4.5% | 2.9% | 4.4% | 4.6% | 9.7% | 3.4% | 1.3% | 3.6% | 3.6% | 5.6% |
| Net Profit Margin | 6.6% | 4.3% | 3.6% | 4.8% | 5.0% | 8.0% | 3.0% | 1.5% | 3.4% | 4.1% | 6.2% |
| Debt to Equity | - | 0.00x | 0.00x | 0.01x | 0.01x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Southern Acids (M) Bhd dividends
- Dividend yield
- 1.66%
- Forward dividend
- 0.05 MYR
- Payout ratio
- 18.3%
- Ex-dividend date
- Oct 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | MYR 6.85M | 0.05 | 18.3% |
| 2025 | MYR 6.85M | 0.05 | 18.7% |
| 2024 | MYR 6.85M | 0.05 | 50.2% |
| 2023 | MYR 6.85M | 0.05 | 20.6% |
| 2022 | MYR 6.85M | 0.05 | 7.3% |
| 2021 | MYR 6.85M | 0.05 | 18.3% |
| 2020 | MYR 6.85M | 0.05 | 21.4% |
| 2019 | MYR 6.85M | 0.05 | 31.9% |
| 2018 | MYR 6.85M | 0.05 | 21.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 812:729 on Oct 18, 1999.
Who owns Southern Acids (M) Bhd
- Insiders 73.80%
- Institutions 11.31%
- Public & others 14.89%
- Shares outstanding 137M
- Free float 36.4M
Southern Acids (M) Bhd company profile
- Company name
- Southern Acids (M) Bhd
- Ticker
- 5134.KLSE
- ISIN
- MYL5134OO001
- Exchange
- Kuala Lumpur Exchange
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Employees
- 1,676
- Fiscal year end
- March
- Address
- Centro Tower, Klang, Malaysia, 41300
- Phone
- 60 3 3258 3333
- Website
- southernacids.com
About Southern Acids (M) Bhd
Southern Acids (M) Berhad, an investment holding company, engages in the manufacture and trading of oleochemical products in Malaysia, Indonesia, rest of Asia, Europe, the United States, and internationally. It operates through four segments: Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The company offers fatty acids and glycerine for use in various applications, including personal care, cleaning agents, cosmetic, pharmaceutical, and food products. It is also involved in the processing of fresh fruit bunches into crude palm oil and palm kernel, as well as oil palm cultivation activities. In addition, the company operates private hospital in Malaysia. Further, it provides plantation; administrative and accounting; overhead conveyor goods loading; warehousing; and port cargo handling services, as well as develops properties and leases a hospital building. The company was incorporated in 1980 and is headquartered in Klang, Malaysia.
Southern Acids (M) Bhd management
7- Dr. Kok Thye LowMD & Acting Non-Independent Executive Chairman · born 1979
- Mr. Kim Long LimNon-Independent Executive Director · born 1960
- Mr. Weng Hoong LeeSenior Finance Manager · born 1972
- Mr. Choon Hoong ChanChief Strategic Development Officer · born 1972
- Ms. Kui Suang Lim FCISCompany Secretary
- Ms. Shu Ling NgCompany Secretary
- Mr. Thevakumar KaliaperumalGeneral Manager of Operation - Milling & Cultivation · born 1971